Kimia Therapeutics
Berkeley
About Kimia Therapeutics
KimiaTherapeutics is a drug discovery business that uses high throughput precision chemistry in conjunction with genome editing and machine learning to uncover druggable sites at crucial nodes of intervention in human disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $55.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2023)
- Website: kimiatx.com
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kimia-therapeutics-117913 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.